Despite the conclusion of RespiVirNet surveillance by the Higher Institute of Health with the last official Bulletin issued on May 3, experts have noted...
The European Medicines Agency (EMA) has approved Ixchiq, the first vaccine against the Chikungunya virus, for marketing. Developed by Valneva, Ixchiq is a single-dose...